Who owns SNTI?
Institutional ownership of Senti Biosciences Holdings Inc. from Form 13F, Q2 2026
18 institutional managers reported holding Senti Biosciences Holdings Inc. (SNTI) in Form 13F filings for Q2 2026, with 2,008,755 shares worth $2.2M. The largest reported holder was Nantahala Capital Management, LLC. 18 opened new positions and 0 sold out.
- Funds holding
- 18
- Value held
- $2.2M
- New / sold out
- 18 / 0
- Net shares, same filers
- None
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of SNTI
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | $977K | 44.2% | 888,000 | New |
| Vanguard Capital Management LLC | $591K | 26.8% | 537,504 | New |
| Geode Capital Management, LLC | $206K | 9.3% | 187,065 | New |
| Citadel Advisors LLC | $118K | 5.3% | 107,100 | New |
| Vanguard Fiduciary Trust Co | $100K | 4.5% | 91,193 | New |
| Jane Street Group, LLC | $58K | 2.6% | 52,530 | New |
| Menlo Ventures Management, L.P. | $39K | 1.8% | 35,737 | New |
| Northern Trust Corp | $35K | 1.6% | 32,154 | New |
| XTX Topco Ltd | $26K | 1.2% | 23,610 | New |
| Virtu Financial LLC | $25K | 1.1% | 22,795 | New |
| UBS Group AG | $16K | 0.7% | 14,432 | New |
| Tower Research Capital LLC (TRC) | $8K | 0.4% | 7,344 | New |
| BlackRock, Inc. | $4K | 0.2% | 4,004 | New |
| Royal Bank of Canada | $4K | 0.2% | 4,015 | New |
| Barclays PLC | $845 | 0.0% | 768 | New |
| SBI Securities Co., Ltd. | $367 | 0.0% | 334 | New |
| Morgan Stanley | $186 | 0.0% | 169 | New |
| Caitong International Asset Management Co., Ltd | $1 | 0.0% | 1 | New |
Share of 13F holdings is each fund's shares as a share of the 2,008,755 SNTI shares all 13F filers reported, not of shares outstanding.
Schedule 13D and 13G filings on SNTI
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-03-17BAYER HEALTHCARE LLC SCHEDULE 13D filed by Senti Biosciences Inc.Schedule 13D
- 2025-02-14ARMISTICE CAPITAL, LLC SCHEDULE 13G filed by Senti Biosciences Inc.Schedule 13G
- 2025-02-14Nantahala Capital Management, LLC SCHEDULE 13G filed by Senti Biosciences Inc.Schedule 13G
- 2025-02-14Nantahala Capital Partners Limited Partnership SCHEDULE 13G filed by Senti Biosciences Inc.Schedule 13G
Questions about SNTI ownership
- Who owns SNTI stock?
- 18 institutional investment managers reported SNTI positions in their Form 13F filings for Q2 2026, holding 2,008,755 shares worth $2.2M in total. Nantahala Capital Management, LLC reported the largest position.
- Are funds buying or selling SNTI?
- 18 managers opened new SNTI positions in Q2 2026.
- How current is this SNTI institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to SNTI by CUSIP. Options are left out. SNTI news and filings · SNTI insider trades · Top funds